iMDsoft Announces that United States Patent Office Re-Examination Successfully Limits Visicu Patent
Published: Feb 27, 2007
BOSTON, Feb. 27 /PRNewswire/ -- The second re-examination requested by iMDsoft of a healthcare services patent owned by Visicu, Inc. has resulted in Visicu limiting all its patent claims.
On February 6, 2007, the United States Patent and Trademark Office (USPTO) held all claims in Visicu's patent No. 6,804,656 to be invalid as not patentable.
The invalidity finding was based on prior art that includes iMDsoft's own patent disclosure, which pre-dates Visicu's patent.
All of the claims in Visicu's patent are affected.
The invalidity rejection by the USPTO forced Visicu on February 15, 2007 to narrow all the patent claims to require that the monitoring and intervention "occurs in an automated fashion at the remote command center" 24 hours per day 7 days per week. There is no "user intervention" or "user input."
Visicu explained that "The patient's care is at all times managed from the remote command center." Visicu advised the USPTO that its patent does not cover "intervention with the patient [that] does not occur in an automated fashion at the central station" or "is manually determined by the emergency service provider or a facility to which the patient is transported by the emergency service provider."
"We were pleased to learn about this important action of the USPTO," says Phyllis Gotlib, iMDsoft's CEO. "It clearly strengthens our competitive position in the market. We always believed that involving medical personnel produces safer medical care. In fact, the new Visicu claims have limited relevance to commercial systems, as virtually all medical care systems utilize medical personnel at some point during the 24/7 monitoring and intervention operations."
Founded in 1996, iMDsoft is leading the critical care Clinical Information and Anesthesia Information Management Systems marketplace, supporting the complete continuum of care in intensive care and perioperative environments including "telemonitoring" programs. iMDsoft 's MetaVision Suite, first commercially implemented in 1999, is a family of products designed to capture, integrate and analyze critical care information enabling improvements in patient care and more effective use of resources. The company - headquartered in Massachusetts and with offices in Europe, Israel, and Japan - is globally recognized for its innovative products and world-class service and support. MetaVision systems are successfully implemented in leading healthcare institutions across three continents.Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070226/CLM182LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, email@example.comMDsoft
CONTACT: Press, Steve Sperrazza, Director of Sales of iMDsoft, Inc.,+1-781-449-5567, or Steve.Sperrazza@imd-soft.com
Web site: http://www.imd-soft.com/